text.skipToContent text.skipToNavigation
Pharma & Biotech

FBMTM Fibroblast Growth Basal Medium, 500 mL

Catalog #: CC-3131

Basal media required for growth of Fibroblasts, 500 mL (supplements and growth factors sold separately).

 

Need a different format or volume for this media product? Contact Lonza CellBio Services to discuss custom format and formulation options.

 

Compare
EA

Product Overview

FBMTM basal medium is a component sold separately. This is part of the FGMTM -2 and FGMTM -3 Fibroblast Growth Media BulletKitsTM (Catalog Numbers CC-3132 and CC-4526, respectively) which consist of basal medium and supplements packaged together.

FGMTM-2 Fibroblast Growth Medium-2 (CC-3132) was developed to support the growth of most primary human fibroblasts including lung and dermal fibroblasts. FGMTM-2 Medium contains 2% serum.

FGMTM-3 Fibroblast Growth Medium-3 (CC-4526) was developed specifically for cardiac fibroblasts. FGMTM-3 Medium contains contains 10% serum.                 

Purchase our Lung Fibroblast Cell Culture Kit (catalog no. CC-2512B) and get a discounted price on cells and media. The kit consists of a cryopreserved ampule of lung fibroblast cells (catalog no. CC-2512) and FGMTM-2 BulletKitTM Growth Media (catalog no. CC-3132)

Content & Storage

Content

1 x FBMTM Basal Medium, 500 mL

Instructions

Safety Data Sheets (SDS)

Certificate of Analysis (CoA)

Please enter Lot Number, including all zeros, located on the product label and please take into account that it is case sensitive.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

Interested in our Webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars. 

Need a Quote or Any Support?

Are Lonza's primary cells and media applicable to your project? Do you need a quote or any help? Contact us and a local representative will get back to you.

We use cookies to deliver the best service to you. By continuing to browse the site, you are agreeing to our use of cookies.Ok